Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.

Loren Laine, Roque Estrada, Mónica Trujillo, Saeed EmamiPubMed 1997

Abstract

Twice-daily RBC-based triple therapy with clarithromycin and amoxicillin produces Helicobacter pylori eradication rates over 90%, which is comparable to rates seen with proton pump inhibitor-based triple therapies. RBC also may be substituted for bismuth subsalicylate and an + H2-receptor antagonist in standard bismuth-based triple therapy.
BibTeX
@inproceedings{laine1997randomized,
  author = {Loren Laine and Roque Estrada and Mónica Trujillo and Saeed Emami},
  title = {{Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.}},
  booktitle = {PubMed},
  year = {1997},
}

Loading related content...

Figure